MX349193B - Capsule with liquid content including an anti-inflammatory. - Google Patents

Capsule with liquid content including an anti-inflammatory.

Info

Publication number
MX349193B
MX349193B MX2013009849A MX2013009849A MX349193B MX 349193 B MX349193 B MX 349193B MX 2013009849 A MX2013009849 A MX 2013009849A MX 2013009849 A MX2013009849 A MX 2013009849A MX 349193 B MX349193 B MX 349193B
Authority
MX
Mexico
Prior art keywords
capsule
inflammatory
content including
liquid content
pharmaceutically acceptable
Prior art date
Application number
MX2013009849A
Other languages
Spanish (es)
Other versions
MX2013009849A (en
Inventor
Senosiain Arroyo Héctor
Barranco Hernández Gustavo
Barrera Ávila José
Original Assignee
Alparis Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis Sa De Cv filed Critical Alparis Sa De Cv
Priority to MX2013009849A priority Critical patent/MX349193B/en
Publication of MX2013009849A publication Critical patent/MX2013009849A/en
Publication of MX349193B publication Critical patent/MX349193B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to a liquid pharmaceutical composition that comprises: a) celecoxib and/or the pharmaceutically acceptable salts thereof; b)one or more binding agents; c) one or more solubility increasing agents; d) one or more solubilizing agents; and e) optionally, one or more pharmaceutically acceptable excipients, all them contained in at least a soft and/or hard capsule. The composition of the present invention is characterized in that it is stable and presents such a dissolution profile that a dissolved percentage higher than or equal to 75% is reached 20 minutes after the intake.
MX2013009849A 2013-08-27 2013-08-27 Capsule with liquid content including an anti-inflammatory. MX349193B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2013009849A MX349193B (en) 2013-08-27 2013-08-27 Capsule with liquid content including an anti-inflammatory.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013009849A MX349193B (en) 2013-08-27 2013-08-27 Capsule with liquid content including an anti-inflammatory.

Publications (2)

Publication Number Publication Date
MX2013009849A MX2013009849A (en) 2015-02-27
MX349193B true MX349193B (en) 2017-07-18

Family

ID=53189301

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009849A MX349193B (en) 2013-08-27 2013-08-27 Capsule with liquid content including an anti-inflammatory.

Country Status (1)

Country Link
MX (1) MX349193B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10799517B2 (en) 2015-05-28 2020-10-13 Dr. Reddy's Laboratories Ltd Oral composition of celecoxib for treatment of pain

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10799517B2 (en) 2015-05-28 2020-10-13 Dr. Reddy's Laboratories Ltd Oral composition of celecoxib for treatment of pain

Also Published As

Publication number Publication date
MX2013009849A (en) 2015-02-27

Similar Documents

Publication Publication Date Title
MX2021014509A (en) Pharmaceutical compositions comprising meloxicam.
MY187047A (en) Selective pyy compounds and uses thereof
NZ734233A (en) Pharmaceutical compositions comprising meloxicam
EA201892395A1 (en) DRUG COMPOSITIONS OF LSD1 INHIBITOR
EA201790528A1 (en) DIHYDROPYRROLOPIRIDINOVYY INHIBITORS ROR-GAMMA
EA201691454A1 (en) COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING
MX2016006053A (en) Selective pyy compounds and uses thereof.
NZ732154A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
PH12015502002A1 (en) Tripeptide epoxy ketone protease inhibitors
MX2015017964A (en) Bromodomain inhibitors.
MX2016012262A (en) Cenicriviroc for the treatment of fibrosis.
IN2013MU01696A (en)
JO3326B1 (en) Tripeptide Epoxy Ketone Protease Inhibitors
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
MX2022001796A (en) Methods and compositions to inhibit symptoms associated with veisalgia.
IN2014MU01042A (en)
AR099299A1 (en) INHIBITOR OF THE CHOLESTERILE ESTER TRANSFER PROTEIN (CETP) AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2017010277A (en) Cenicriviroc for the treatment of fibrosis.
WO2019004788A3 (en) Pharmaceutical composition containing broussochalcone a as active ingredient for prevention or treatment of inflammatory bowel disease
MX2021003230A (en) Pharmaceutical compositions comprising meloxicam.
MX2016010892A (en) Agent for improving or preventing progression of chronic kidney disease.
MX2016016039A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof.
MX2013001279A (en) Pharmaceutical composition with a selective enzyme phosphodiesterase inhibitor in an oral gel form.

Legal Events

Date Code Title Description
FG Grant or registration